A Leawood woman is facing federal charges of importing drugs that allegedly did not contain labeling approved by the government.
Kathleen Stegman, 59, was charged Friday in U.S. District Court in Kansas City, Kan., with importing about $194,000 worth of misbranded drugs.
Prosecutors said that Stegman, who owned Midwest Medical Aesthetics Center Inc. in Leawood, obtained Botox, Dysport, Restylane, Perlane and Sculptra from foreign sources.
The drugs did not contain labeling required by the Food and Drug Administration, according to the allegations.
She was sentenced last year to four years and three months in prison for tax evasion. She is currently serving the sentence at a minimum security facility in West Virginia, according to the U.S. Bureau of Prisons.
The new charges carry a sentence of up to three years in prison, prosecutors said.